Affinage · Plasmodium

RH2a

PF3D7_1335400 · reticulocyte binding protein 2 homologue a

Annotated
2026-09-08
28 papers in source corpus 14 papers cited in narrative 14 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

RH2a (PF3D7_1335400) is a >300 kDa apical merozoite protein of the reticulocyte binding-like family that participates in erythrocyte invasion by Plasmodium falciparum, contributing to the selection of alternative invasion pathways (PMID:12606570, PMID:30496294). It is expressed in late schizonts and merozoites and localizes to apical organelles and the apical merozoite surface, with antibodies against it inhibiting invasion (PMID:11160005, PMID:12228308). Unlike its paralog PfRh2b, disruption of RH2a does not by itself specify the sialic acid-independent, trypsin-resistant, chymotrypsin-sensitive invasion pathway, but both paralogs contribute to efficient sialic acid-independent invasion, and their variant expression at the PfRh2a/PfRh2b locus is the single major genetic determinant of invasion-pathway phenotype (PMID:12606570, PMID:19400777, PMID:30496294). The two paralogs share a conserved N-terminal ectodomain — mapped to a 15–40 kDa region — that mediates erythrocyte binding, while their functional divergence is conferred by their divergent cytoplasmic domains rather than the ectodomain or transmembrane region (PMID:20487292, PMID:21386888, PMID:21698217). RH2a is proteolytically processed both in the schizont and during invasion, including transmembrane cleavage consistent with the rhomboid protease PfROM4, yielding fragments with distinct erythrocyte binding specificities, and it translocates from the rhoptry neck to the moving junction during invasion independently of the pathway used (PMID:17040128, PMID:21698217, PMID:21628513). The RH2a cytoplasmic tail does not bind aldolase — in contrast to RH2b — explaining why RH2a is not directly coupled to the actin-myosin motor and is functionally distinct from RH2b (PMID:22991428). Relative to PfRH1 and PfRh2b, RH2a is a minor target of acquired human growth-inhibitory antibodies (PMID:40201183).

Mechanistic history

Synthesis pass · year-by-year structured walk · 13 steps
  1. 2001 Medium

    Establishing where and when RH2a acts was the first requirement; its identification as a large apical schizont/merozoite protein whose antibodies block invasion placed it at the invasion interface.

    Evidence Protein expression analysis, immunofluorescence, erythrocyte binding and antibody invasion-inhibition assays in P. falciparum

    PMID:11160005

    Open questions at the time
    • No direct erythrocyte binding detected in this assay
    • Receptor and molecular function undefined
  2. 2002 Medium

    Whether RH2a expression is uniform across parasites was addressed by showing variable transcription/translation across lines, establishing RH2a as subject to phenotypic variation at the protein level.

    Evidence Western blot, immunofluorescence and RT-PCR across multiple parasite lines (3D7, T996, FCB1) in P. falciparum

    PMID:12228308

    Open questions at the time
    • Mechanism controlling variant expression not defined
    • Consequence of expression variation for invasion untested here
  3. 2003 High

    The question of whether RH2a and RH2b are functionally interchangeable was answered by disruption showing RH2a, unlike RH2b, does not mediate the sialic acid-independent invasion pathway, framing invasion-pathway variation as receptor exploitation.

    Evidence Targeted gene disruption with enzyme-treated RBC invasion assays in P. falciparum

    PMID:12606570

    Open questions at the time
    • Positive function of RH2a itself not defined
    • Molecular basis of paralog divergence unknown
  4. 2006 Medium

    How RH2a is released from the merozoite surface was probed by identifying it as a substrate of the rhomboid protease PfROM4, establishing a candidate mechanism for transmembrane processing during invasion.

    Evidence Heterologous rhomboid cleavage assay with transmembrane-domain swaps in P. falciparum

    PMID:17040128

    Open questions at the time
    • Cleavage shown in heterologous system, not in native parasite
    • Functional consequence of cleavage untested here
  5. 2009 High

    Reciprocal disruptions clarified that RH2a is not merely redundant, showing both paralogs contribute to efficient sialic acid-independent invasion and that selection favors RH2b over RH2a expression.

    Evidence Individual PfRh2a and PfRh2b knockouts with sialic acid-depleted erythrocyte invasion assays in W2mef P. falciparum

    PMID:19400777

    Open questions at the time
    • Quantitative contribution of RH2a alone not fully separable
    • Basis of selective pressure toward RH2b unexplained
  6. 2010 High

    The domain responsible for functional divergence between the paralogs was mapped by chimeras to the cytoplasmic domain, localizing pathway specification to intracellular signaling rather than receptor binding.

    Evidence PfRh2a/2b domain-swap chimeric parasites with invasion pathway assays in P. falciparum

    PMID:20487292

    Open questions at the time
    • Cytoplasmic-domain binding partners not identified in this study
    • How the tail transduces pathway choice unknown
  7. 2010 Medium

    Whether RH2 acts alone was tested by showing EBA-181 loss abolishes RH2a/b antibody inhibition, establishing functional cooperation between PfRh and EBL protein families.

    Evidence eba gene knockouts combined with antibody growth-inhibition assays in P. falciparum

    PMID:21149582

    Open questions at the time
    • Direct physical interaction not demonstrated
    • RH2a-specific vs RH2b-specific cooperation not separated
  8. 2011 Medium

    Multiple studies defined how processing generates functionally distinct fragments and mapped the erythrocyte-binding activity to a conserved N-terminal ectodomain (15–40 kDa) shared with RH2b.

    Evidence Native protein processing western blots, enzyme-treated RBC binding assays, recombinant domain mapping and antibody inhibition in P. falciparum

    PMID:21386888 PMID:21698217

    Open questions at the time
    • Erythrocyte receptor for the binding domain not identified
    • Assays largely single-lab
  9. 2011 Medium

    Tracking RH2a during live invasion revealed pathway-independent translocation from rhoptry neck to moving junction, implying a role beyond receptor binding.

    Evidence Live and fixed immunofluorescence with anti-PfRH2a monoclonal antibodies and binding assays of processed fragments in P. falciparum

    PMID:21628513

    Open questions at the time
    • The moving-junction function of RH2a is not mechanistically defined
    • Interactions at the junction not identified
  10. 2012 High

    The mechanistic basis of RH2a/RH2b functional distinction was resolved biochemically: the RH2a cytoplasmic tail does not bind aldolase, unlike RH2b, explaining why RH2a is not coupled to the actin-myosin motor.

    Evidence Peptide binding, surface plasmon resonance and X-ray crystallography of aldolase with the RH2b tail as comparator in P. falciparum

    PMID:22991428

    Open questions at the time
    • Alternative binding partners of the RH2a tail not identified
    • Whether RH2a couples to the motor by another route unknown
  11. 2013 Low

    A screen for heparin-binding surface proteins included RH2a among apical merozoite ligands, offering a possible route by which heparin masks invasion ligands.

    Evidence Heparin affinity chromatography, immunoblot and immunofluorescence in P. falciparum

    PMID:24212193

    Open questions at the time
    • Single pulldown without RH2a-specific functional follow-up
    • Physiological relevance of heparin binding for RH2a untested
  12. 2018 High

    Genetics established the causal locus: forward linkage and CRISPR-Cas9 editing identified the PfRh2a/PfRh2b locus as the single major determinant of alternative invasion-pathway phenotype.

    Evidence Forward genetic cross linkage analysis and CRISPR-Cas9 editing with invasion phenotyping in P. falciparum

    PMID:30496294

    Open questions at the time
    • Precise contribution of RH2a versus RH2b expression at the locus not fully partitioned
    • Molecular switch controlling expression not defined
  13. 2025 Medium

    The relative immunological importance of RH2a was assessed by showing its disruption has a smaller effect on susceptibility to human inhibitory antibodies than PfRH1 or RH2b loss, ranking RH2a as a minor immune-evasion contributor.

    Evidence pfrh2a knockout parasites challenged with human immune sera in invasion inhibition assays in P. falciparum

    PMID:40201183

    Open questions at the time
    • Epitopes and antibody targets on RH2a not mapped
    • Single study

Open questions

Synthesis pass · forward-looking unresolved questions
  • The intracellular signaling role of the RH2a cytoplasmic tail and its binding partners at the moving junction remain unresolved, leaving open how RH2a functions during invasion beyond ectodomain receptor binding.
  • No RH2a cytoplasmic-tail interactor identified
  • Erythrocyte receptor for the RH2a ectodomain unknown
  • Function at the moving junction undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification

Evidence

Reading pass · 14 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2003 Targeted gene disruption of PfRh2a in P. falciparum showed that unlike PfRh2b, PfRh2a does not mediate the novel sialic acid-independent, trypsin-resistant, chymotrypsin-sensitive invasion pathway, and phenotypic variation (variant expression) of the PfRh protein family allows exploitation of different erythrocyte surface receptors. Targeted gene disruption (knockout) with erythrocyte invasion assays using enzyme-treated RBCs The EMBO journal High 12606570
2001 RH2a (PF3D7_1335400) encodes a >300 kDa protein expressed in late schizonts and localized to the apical end of the merozoite; no binding to mature RBCs or reticulocyte-enriched cell preparations was detected in this study, and antibodies to the protein can inhibit merozoite invasion of RBCs. Protein expression analysis, immunofluorescence localization, erythrocyte binding assay, invasion inhibition assay with antibodies Infection and immunity Medium 11160005
2002 RH2a protein is expressed in late schizonts and merozoites and is located in apical organelles and on the apical surface; expression of RH2a is variably transcribed and translated across parasite lines (absent in FCB1), indicating phenotypic variation at the protein level. Western blot, immunofluorescence, RT-PCR across multiple parasite lines Infection and immunity Medium 12228308
2006 PfROM4 (a P. falciparum rhomboid intramembrane protease) cleaves RH2a in a heterologous processing assay, with cleavage dependent on the RH2a transmembrane domain; PfROM1 did not cleave RH2a efficiently in this assay. Heterologous rhomboid cleavage assay with substrate transmembrane domain swap experiments PLoS pathogens Medium 17040128
2009 Targeted gene disruption of PfRh2a and PfRh2b separately in W2mef parasites showed that both PfRh2b and PfRh2a contribute to efficient sialic acid-independent erythrocyte invasion, and there is strong selective pressure for reconstitution of PfRh2b expression at the expense of PfRh2a expression. Targeted gene disruption (knockout) of PfRh2a and PfRh2b individually with invasion assays using sialic acid-depleted erythrocytes Molecular microbiology High 19400777
2010 The differential ability of PfRh2a vs. PfRh2b to specify alternative erythrocyte invasion pathways is conferred by their divergent cytoplasmic domains, not by the ectodomain or transmembrane regions, as shown using viable PfRh2a/2b chimeric parasites. Generation of chimeric parasites (domain-swap constructs of PfRh2a and PfRh2b) with invasion pathway assays Molecular microbiology High 20487292
2010 Loss of function of EBA-181 ablates the ability of PfRh2a/b antibodies to inhibit merozoite invasion, providing evidence that PfRh and EBL proteins functionally interact and work cooperatively during merozoite invasion. Single and double gene knockouts of eba genes combined with antibody invasion inhibition assays (growth inhibition assay) Infection and immunity Medium 21149582
2011 Native PfRH2a/2b is proteolytically processed near the N-terminus yielding a 220 kDa fragment (sialic acid-independent, trypsin-resistant, chymotrypsin-sensitive erythrocyte binding) and an 80 kDa fragment (sialic acid-dependent, trypsin-resistant, chymotrypsin-sensitive erythrocyte binding); the erythrocyte binding domain was mapped to a conserved 40 kDa N-terminal region common to both PfRH2a and PfRH2b, and recombinant protein of this domain blocks sialic acid-independent invasion. Western blot of native protein processing, erythrocyte binding assays with enzyme-treated RBCs, recombinant protein binding, invasion inhibition with antibodies PloS one Medium 21386888
2011 PfRh2a undergoes proteolytic cleavage events in the transmembrane region during invasion consistent with PfROM4 activity, releasing the ectodomain; PfRh2a and PfRh2b bind red blood cells and the erythrocyte-binding domain was defined to a 15 kDa N-terminal region of each protein; antibodies to this region block merozoite invasion. Proteolytic processing analysis (western blot), erythrocyte binding assay, antibody invasion inhibition assay PLoS pathogens Medium 21698217
2011 Using monoclonal antibodies against a unique region of PfRH2a, PfRH2a was shown to translocate from the rhoptry neck to the moving junction during merozoite invasion, independent of the invasion pathway used, suggesting a function beyond receptor binding; PfRH2a is processed both in the schizont and during invasion, producing fragments with different erythrocyte binding properties. Live and fixed immunofluorescence with anti-PfRH2a monoclonal antibodies, erythrocyte binding assays with processed fragments Infection and immunity Medium 21628513
2012 Aldolase does NOT bind the cytoplasmic tail of RH2a (only RH2b binds aldolase among the two paralogs), indicating RH2a lacks the aromatic amino acid context required for connection to the actin-myosin motor via aldolase; this is consistent with the functional distinction that RH2b but not RH2a is required for erythrocyte invasion. Peptide binding assay, surface plasmon resonance (SPR), X-ray crystal structure of aldolase with RH2b cytoplasmic peptide mBio High 22991428
2013 RH2a (as a member of the reticulocyte binding-like family) binds heparin, localizing to the apical tip of the merozoite surface; heparin affinity chromatography followed by immunoblot confirmed heparin binding, suggesting heparin masks the apical surface and blocks erythrocyte interaction. Heparin affinity chromatography, immunoblot with ligand-specific antibodies, immunofluorescence localization Scientific reports Low 24212193
2018 Forward genetic linkage analysis of experimental genetic crosses identified the PfRh2a/PfRh2b locus as the single major determinant of phenotypic variation in two erythrocyte invasion pathways; CRISPR-Cas9 editing confirmed that variation in PfRh2a and PfRh2b expression specifies alternative invasion pathway use. Forward genetic screen, whole genome sequencing linkage analysis of genetic cross progeny, CRISPR-Cas9 gene editing, invasion pathway phenotyping PLoS pathogens High 30496294
2025 Disruption of pfrh2a in P. falciparum had a less prominent effect on susceptibility to human inhibitory antibodies compared to loss of PfRH1 or PfRH2b, suggesting PfRH2a is a minor target of acquired growth-inhibitory antibodies and plays a lesser role in immune evasion through phenotypic variation relative to PfRH1 and PfRH2b. Gene disruption (pfrh2a knockout) parasites challenged with human immune sera in invasion inhibition assays Frontiers in immunology Medium 40201183

Source papers

Stage 0 corpus · 28 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2003 Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. The EMBO journal 224 12606570
2006 Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria. PLoS pathogens 180 17040128
2010 Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites. Infection and immunity 117 21149582
2001 Identification of proteins from Plasmodium falciparum that are homologous to reticulocyte binding proteins in Plasmodium vivax. Infection and immunity 112 11160005
2002 Variation in the expression of a Plasmodium falciparum protein family implicated in erythrocyte invasion. Infection and immunity 89 12228308
2010 Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria. Journal of immunology (Baltimore, Md. : 1950) 76 20962255
2011 Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PloS one 58 21386888
2007 Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif. PloS one 57 17653272
2005 Dramatic difference in diversity between Plasmodium falciparum and Plasmodium vivax reticulocyte binding-like genes. The American journal of tropical medicine and hygiene 53 15964948
2007 Molecular analysis of erythrocyte invasion in Plasmodium falciparum isolates from Senegal. Infection and immunity 42 17470537
2011 Plasmodium falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a and b binding domains. PLoS pathogens 40 21698217
2015 Variation in Plasmodium falciparum erythrocyte invasion phenotypes and merozoite ligand gene expression across different populations in areas of malaria endemicity. Infection and immunity 37 25870227
2010 Functional diversification between two related Plasmodium falciparum merozoite invasion ligands is determined by changes in the cytoplasmic domain. Molecular microbiology 36 20487292
2013 Analyses of interactions between heparin and the apical surface proteins of Plasmodium falciparum. Scientific reports 32 24212193
2012 Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru. Malaria journal 32 23110555
2012 Plasmodium falciparum field isolates from South America use an atypical red blood cell invasion pathway associated with invasion ligand polymorphisms. PloS one 26 23118907
2009 Cooperativity between Plasmodium falciparum adhesive proteins for invasion into erythrocytes. Molecular microbiology 24 19400777
2011 Differences in erythrocyte receptor specificity of different parts of the Plasmodium falciparum reticulocyte binding protein homologue 2a. Infection and immunity 23 21628513
2016 PfRH2b specific monoclonal antibodies inhibit merozoite invasion. Molecular microbiology 15 27438226
2018 A forward genetic screen reveals a primary role for Plasmodium falciparum Reticulocyte Binding Protein Homologue 2a and 2b in determining alternative erythrocyte invasion pathways. PLoS pathogens 13 30496294
2012 Binding of aldolase and glyceraldehyde-3-phosphate dehydrogenase to the cytoplasmic tails of Plasmodium falciparum merozoite duffy binding-like and reticulocyte homology ligands. mBio 13 22991428
2021 Suitability of IgG responses to multiple Plasmodium falciparum antigens as markers of transmission intensity and pattern. PloS one 8 33886601
2012 Co-expression network with protein-protein interaction and transcription regulation in malaria parasite Plasmodium falciparum. Gene 7 23274650
2023 High opsonic phagocytosis activity and growth inhibition of merozoites are associated with RON4 antibody levels and protect against febrile malaria in Ghanaian children. Frontiers in immunology 5 37197657
2020 Population genetic and biophysical evidences reveal that purifying selection shapes the genetic landscape of Plasmodium falciparum RH ligands in Chhattisgarh and West Bengal, India. Malaria journal 3 33054833
2014 Antibody response against three Plasmodium falciparum merozoite antigens in Mamuju District, West Sulawesi Province, Indonesia. Malaria journal 3 25255775
2025 Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion. Frontiers in immunology 2 40201183
2009 Case-control approach to identify Plasmodium falciparum polymorphisms associated with severe malaria. PloS one 2 19421327